Corridor · Sourcing Intelligence
Akunudo screens manufacturers of Semaglutide Injection 1.0mg/1.5ml for Qatar registration before you ever see them — certification, stability zone for the climate, and dossier format clear first; commercial fit second. Identities stay sealed until NDA, so you can source without tipping your hand.
2
vetted manufacturers
1
EU-GMP listed
80
top alignment
Not a directory to wade through — a brokered, anonymized corridor. We only fully win when your deal closes.
Market access · Qatar
Registration via the MoPH Pharmacy & Drug Control Department with a Qatari local agent, and access to the Gulf Health Council's centralised (reliance) route for products already cleared by reference agencies or other GCC states. High-price GCC market: prices are set by external reference pricing within the GCC unified-pricing framework plus a regulated cumulative mark-up (~44%). Public access runs through HMC and PHCC for health-card holders.
The MoPH Pharmacy & Drug Control Department (PDCD) registers medicines: the local agent files the application through the PDCD e-system, which runs administrative screening, scientific/technical review and a pricing review before a registration certificate issues.
CTD, submitted electronically (eCTD) and aligned with the GCC common technical requirements.
Yes — a Qatari-registered local agent/representative is mandatory; a foreign manufacturer cannot register, import or sell directly.
Yes. The Gulf Health Council's centralised committee (GCC-DR) applies an abridged/reliance review for products already approved by two GCC states or by a reference agency (US-FDA, EMA, or WHO-prequalification); a central decision can follow within roughly 60 days of the member-state scientific reports. Confirm Qatar-specific uptake with the authority.
Yes — a legalised GMP certificate from the country of origin is required, and the GHC/PDCD may inspect the manufacturing site.
Orientation intelligence compiled from public regulator and analyst sources as of the dates shown — not legal or regulatory advice. Rules change; confirm specifics (fees, timelines, baskets, eligibility) with the authority before acting. (Authority: MoPH — Ministry of Public Health (Pharmacy & Drug Control Department); as of 2026-06.)